When combined with semaglutide (the CagriSema combination), it produced 22.7% weight loss in Phase 3 trials
*Please be advised that returns are accepted ONLY IF you followed the instructions above and your return request has been approved by our staff
The medication reaches steady-state concentrations after approximately four to five weeks of regular dosing, creating a stable therapeutic effect
The body appears to adapt to regular peptide exposure, with the immune response moderating over time
The active ingredient, Melanotan II, has been linked to a number of side effects, including nausea, vomiting, diarrhea, dizziness, loss of appetite, facial flushing, and increased pigmentation of the skin and nails
As the new year approaches, why wait for symptoms to appear before taking action